Asset Management
Compare Stocks
5 / 10Stock Comparison
DHIL vs VRTS vs GROW vs HNNA vs CSWC
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
Asset Management - Global
Asset Management
Asset Management
DHIL vs VRTS vs GROW vs HNNA vs CSWC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Asset Management | Asset Management | Asset Management - Global | Asset Management | Asset Management |
| Market Cap | $473M | $949M | $35M | $81M | $1.43B |
| Revenue (TTM) | $158M | $831M | $8M | $36M | $164M |
| Net Income (TTM) | $49M | $138M | $98K | $8M | $103M |
| Gross Margin | 96.0% | 74.9% | 41.7% | 70.1% | 66.5% |
| Operating Margin | 38.4% | 17.4% | -35.3% | 37.0% | 48.5% |
| Forward P/E | 9.5x | 5.5x | — | 8.0x | 10.1x |
| Total Debt | $6.40B | $2.84B | $83K | $41M | $956M |
| Cash & Equiv. | $42M | $477M | $25M | $72M | $43M |
DHIL vs VRTS vs GROW vs HNNA vs CSWC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | Apr 26 | Return |
|---|---|---|---|
| Diamond Hill Invest… (DHIL) | 100 | 166.7 | +66.7% |
| Virtus Investment P… (VRTS) | 100 | 144.5 | +44.5% |
| U.S. Global Investo… (GROW) | 100 | 118.7 | +18.7% |
| Hennessy Advisors, … (HNNA) | 100 | 121.9 | +21.9% |
| Capital Southwest C… (CSWC) | 100 | 158.2 | +58.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: DHIL vs VRTS vs GROW vs HNNA vs CSWC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
DHIL is the clearest fit if your priority is defensive.
- Beta 0.57, yield 5.7%, current ratio 75115.85x
VRTS is the #2 pick in this set and the best alternative if valuation efficiency is your priority.
- PEG 0.38 vs HNNA's 2.18
- Lower P/E (5.5x vs 10.1x)
- 6.6% yield, 7-year raise streak, vs CSWC's 10.2%
Among these 5 stocks, GROW doesn't own a clear edge in any measured category.
HNNA ranks third and is worth considering specifically for growth exposure and sleep-well-at-night.
- Rev growth 19.9%, EPS growth 38.0%
- Lower volatility, beta 0.30, Low D/E 41.4%, current ratio 12.72x
- 19.9% NII/revenue growth vs GROW's -23.1%
- Beta 0.30 vs VRTS's 1.14, lower leverage
CSWC carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 3 yrs, beta 0.84, yield 10.2%
- 234.2% 10Y total return vs VRTS's 142.6%
- NIM 7.0% vs DHIL's 0.7%
- Efficiency ratio 0.2% vs GROW's 0.8% (lower = leaner)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 19.9% NII/revenue growth vs GROW's -23.1% | |
| Value | Lower P/E (5.5x vs 10.1x) | |
| Quality / Margins | Efficiency ratio 0.2% vs GROW's 0.8% (lower = leaner) | |
| Stability / Safety | Beta 0.30 vs VRTS's 1.14, lower leverage | |
| Dividends | 6.6% yield, 7-year raise streak, vs CSWC's 10.2% | |
| Momentum (1Y) | +34.0% vs VRTS's -5.5% | |
| Efficiency (ROA) | Efficiency ratio 0.2% vs GROW's 0.8% |
DHIL vs VRTS vs GROW vs HNNA vs CSWC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
DHIL vs VRTS vs GROW vs HNNA vs CSWC — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CSWC leads in 2 of 6 categories
VRTS leads 1 • DHIL leads 0 • GROW leads 0 • HNNA leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CSWC leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
VRTS is the larger business by revenue, generating $831M annually — 98.3x GROW's $8M. CSWC is the more profitable business, keeping 43.1% of every revenue dollar as net income compared to GROW's -4.0%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $158M | $831M | $8M | $36M | $164M |
| EBITDAEarnings before interest/tax | $62M | $205M | -$2M | $11M | $142M |
| Net IncomeAfter-tax profit | $49M | $138M | $98,000 | $8M | $103M |
| Free Cash FlowCash after capex | $44.5B | -$67M | -$235,000 | $10M | -$69M |
| Gross MarginGross profit ÷ Revenue | +96.0% | +74.9% | +41.7% | +70.1% | +66.5% |
| Operating MarginEBIT ÷ Revenue | +38.4% | +17.4% | -35.3% | +37.0% | +48.5% |
| Net MarginNet income ÷ Revenue | +30.9% | +16.7% | -4.0% | +28.0% | +43.1% |
| FCF MarginFCF ÷ Revenue | -57.4% | -8.9% | -9.8% | +37.6% | -132.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +25.3% | +10.9% | — | -27.3% | +113.3% |
Valuation Metrics
VRTS leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 7.1x trailing earnings, VRTS trades at a 56% valuation discount to CSWC's 16.3x P/E. Adjusting for growth (PEG ratio), VRTS offers better value at 0.48x vs HNNA's 2.18x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $473M | $949M | $35M | $81M | $1.4B |
| Enterprise ValueMkt cap + debt − cash | $6.8B | $3.3B | $10M | $49M | $2.3B |
| Trailing P/EPrice ÷ TTM EPS | 9.77x | 7.10x | -104.80x | 8.03x | 16.32x |
| Forward P/EPrice ÷ next-FY EPS est. | 9.48x | 5.55x | — | — | 10.06x |
| PEG RatioP/E ÷ EPS growth rate | 1.18x | 0.48x | — | 2.18x | — |
| EV / EBITDAEnterprise value multiple | 110.39x | 16.20x | — | 3.62x | 27.43x |
| Price / SalesMarket cap ÷ Revenue | 3.00x | 1.14x | 4.14x | 2.27x | 8.71x |
| Price / BookPrice ÷ Book value/share | 2.70x | 0.95x | 0.77x | 0.82x | 1.39x |
| Price / FCFMarket cap ÷ FCF | — | — | — | 6.03x | — |
Profitability & Efficiency
Evenly matched — DHIL and GROW and HNNA each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
DHIL delivers a 27.0% return on equity — every $100 of shareholder capital generates $27 in annual profit, vs $0 for GROW. GROW carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to DHIL's 36.26x. On the Piotroski fundamental quality scale (0–9), HNNA scores 7/9 vs CSWC's 1/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +27.0% | +13.5% | +0.2% | +8.5% | +10.3% |
| ROA (TTM)Return on assets | +19.5% | +3.6% | +0.2% | +5.3% | +4.8% |
| ROICReturn on invested capital | +1.3% | +3.0% | -4.7% | +7.3% | +3.5% |
| ROCEReturn on capital employed | +26.0% | +3.7% | -6.2% | +8.7% | +4.6% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 2 | 7 | 1 |
| Debt / EquityFinancial leverage | 36.26x | 2.74x | 0.00x | 0.41x | 1.08x |
| Net DebtTotal debt minus cash | $6.4B | $2.4B | -$24M | -$32M | $913M |
| Cash & Equiv.Liquid assets | $42M | $477M | $25M | $72M | $43M |
| Total DebtShort + long-term debt | $6.4B | $2.8B | $83,000 | $41M | $956M |
| Interest CoverageEBIT ÷ Interest expense | — | 2.15x | 600.00x | 9.62x | 2.91x |
Total Returns (Dividends Reinvested)
CSWC leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CSWC five years ago would be worth $15,138 today (with dividends reinvested), compared to $4,143 for GROW. Over the past 12 months, CSWC leads with a +34.0% total return vs VRTS's -5.5%. The 3-year compound annual growth rate (CAGR) favors CSWC at 20.7% vs VRTS's 0.0% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +2.8% | -9.8% | +7.7% | +7.4% | +11.4% |
| 1-Year ReturnPast 12 months | +33.8% | -5.5% | +27.8% | +1.2% | +34.0% |
| 3-Year ReturnCumulative with dividends | +22.4% | +0.1% | +3.3% | +66.8% | +75.8% |
| 5-Year ReturnCumulative with dividends | +28.3% | -35.0% | -58.6% | +37.6% | +51.4% |
| 10-Year ReturnCumulative with dividends | +55.4% | +142.6% | +67.4% | -35.0% | +234.2% |
| CAGR (3Y)Annualised 3-year return | +7.0% | +0.0% | +1.1% | +18.6% | +20.7% |
Risk & Volatility
Evenly matched — DHIL and HNNA each lead in 1 of 2 comparable metrics.
Risk & Volatility
HNNA is the less volatile stock with a 0.30 beta — it tends to amplify market swings less than VRTS's 1.14 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DHIL currently trades 100.0% from its 52-week high vs VRTS's 65.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.57x | 1.14x | 0.71x | 0.30x | 0.84x |
| 52-Week HighHighest price in past year | $175.03 | $215.06 | $3.65 | $13.19 | $24.43 |
| 52-Week LowLowest price in past year | $114.11 | $121.61 | $2.10 | $8.90 | $19.37 |
| % of 52W HighCurrent price vs 52-week peak | +100.0% | +65.9% | +71.8% | +77.3% | +98.2% |
| RSI (14)Momentum oscillator 0–100 | 70.5 | 55.4 | 46.5 | 51.6 | 63.7 |
| Avg Volume (50D)Average daily shares traded | 23K | 101K | 25K | 9K | 664K |
Analyst Outlook
Evenly matched — VRTS and CSWC each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: VRTS as "Hold", CSWC as "Buy". Consensus price targets imply 15.0% upside for VRTS (target: $163) vs -6.2% for CSWC (target: $23). For income investors, CSWC offers the higher dividend yield at 10.20% vs GROW's 3.46%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | — | — | Buy |
| Price TargetConsensus 12-month target | — | $163.00 | — | — | $22.50 |
| # AnalystsCovering analysts | — | 11 | — | — | 10 |
| Dividend YieldAnnual dividend ÷ price | +5.7% | +6.6% | +3.5% | +5.3% | +10.2% |
| Dividend StreakConsecutive years of raises | 1 | 7 | 1 | 1 | 3 |
| Dividend / ShareAnnual DPS | $9.98 | $9.32 | $0.09 | $0.54 | $2.45 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.6% | +6.3% | +5.6% | +0.6% | 0.0% |
CSWC leads in 2 of 6 categories (Income & Cash Flow, Total Returns). VRTS leads in 1 (Valuation Metrics). 3 tied.
DHIL vs VRTS vs GROW vs HNNA vs CSWC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is DHIL or VRTS or GROW or HNNA or CSWC a better buy right now?
For growth investors, Hennessy Advisors, Inc.
(HNNA) is the stronger pick with 19. 9% revenue growth year-over-year, versus -23. 1% for U. S. Global Investors, Inc. (GROW). Virtus Investment Partners, Inc. (VRTS) offers the better valuation at 7. 1x trailing P/E (5. 5x forward), making it the more compelling value choice. Analysts rate Capital Southwest Corporation (CSWC) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — DHIL or VRTS or GROW or HNNA or CSWC?
On trailing P/E, Virtus Investment Partners, Inc.
(VRTS) is the cheapest at 7. 1x versus Capital Southwest Corporation at 16. 3x. On forward P/E, Virtus Investment Partners, Inc. is actually cheaper at 5. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Virtus Investment Partners, Inc. wins at 0. 38x versus Diamond Hill Investment Group, Inc. 's 1. 14x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — DHIL or VRTS or GROW or HNNA or CSWC?
Over the past 5 years, Capital Southwest Corporation (CSWC) delivered a total return of +51.
4%, compared to -58. 6% for U. S. Global Investors, Inc. (GROW). Over 10 years, the gap is even starker: CSWC returned +234. 2% versus HNNA's -35. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — DHIL or VRTS or GROW or HNNA or CSWC?
By beta (market sensitivity over 5 years), Hennessy Advisors, Inc.
(HNNA) is the lower-risk stock at 0. 30β versus Virtus Investment Partners, Inc. 's 1. 14β — meaning VRTS is approximately 275% more volatile than HNNA relative to the S&P 500. On balance sheet safety, U. S. Global Investors, Inc. (GROW) carries a lower debt/equity ratio of 0% versus 36% for Diamond Hill Investment Group, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — DHIL or VRTS or GROW or HNNA or CSWC?
By revenue growth (latest reported year), Hennessy Advisors, Inc.
(HNNA) is pulling ahead at 19. 9% versus -23. 1% for U. S. Global Investors, Inc. (GROW). On earnings-per-share growth, the picture is similar: Hennessy Advisors, Inc. grew EPS 38. 0% year-over-year, compared to -126. 6% for U. S. Global Investors, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — DHIL or VRTS or GROW or HNNA or CSWC?
Capital Southwest Corporation (CSWC) is the more profitable company, earning 43.
1% net margin versus -4. 0% for U. S. Global Investors, Inc. — meaning it keeps 43. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CSWC leads at 48. 5% versus -35. 3% for GROW. At the gross margin level — before operating expenses — DHIL leads at 96. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is DHIL or VRTS or GROW or HNNA or CSWC more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Virtus Investment Partners, Inc. (VRTS) is the more undervalued stock at a PEG of 0. 38x versus Diamond Hill Investment Group, Inc. 's 1. 14x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Virtus Investment Partners, Inc. (VRTS) trades at 5. 5x forward P/E versus 10. 1x for Capital Southwest Corporation — 4. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for VRTS: 15. 0% to $163. 00.
08Which pays a better dividend — DHIL or VRTS or GROW or HNNA or CSWC?
All stocks in this comparison pay dividends.
Capital Southwest Corporation (CSWC) offers the highest yield at 10. 2%, versus 3. 5% for U. S. Global Investors, Inc. (GROW).
09Is DHIL or VRTS or GROW or HNNA or CSWC better for a retirement portfolio?
For long-horizon retirement investors, Hennessy Advisors, Inc.
(HNNA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 30), 5. 3% yield). Both have compounded well over 10 years (HNNA: -35. 0%, VRTS: +142. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between DHIL and VRTS and GROW and HNNA and CSWC?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: DHIL is a small-cap deep-value stock; VRTS is a small-cap deep-value stock; GROW is a small-cap income-oriented stock; HNNA is a small-cap high-growth stock; CSWC is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.